A Comparative Study of the Behavioral Profile of the Behavioral Variant of Frontotemporal Dementia and Parkinson’s Disease Dementia

<b><i>Background:</i></b> Executive dysfunction is the common thread between pure cortical dementia like the behavioral variant of frontotemporal dementia (bvFTD) and subcortical dementia like Parkinson’s disease dementia (PDD). Although there are clinical and cognitive features to differentiate cortical and subcortical dementia, the behavioral symptoms differentiating these 2 conditions are still not well known. <b><i>Objective:</i></b> To evaluate the behavioral profile of bvFTD and PDD and compare them to find out which behavioral symptoms can differentiate between the two. <b><i>Methods:</i></b> Twenty consecutive patients with bvFTD (&#x3e;1 year after diagnosis) and 20 PDD patients were recruited according to standard diagnostic criteria. Behavioral symptoms were collected from the reliable caregiver by means of a set of questionnaires and then compared between the 2 groups. <b><i>Results:</i></b> bvFTD patients had more severe disease and more behavioral symptoms than PDD. bvFTD patients were different from PDD patients due to their significantly greater: loss of basic emotion (<i>p</i> &#x3c; 0.001, odds ratio [OR] 44.33), loss of awareness of pain (<i>p</i> &#x3c; 0.001, OR 44.33), disinhibition (<i>p</i> &#x3c; 0.001, OR 35.29), utilization phenomenon (<i>p</i> = 0.008, OR 22.78), loss of taste discrimination (<i>p</i> &#x3c; 0.001, OR 17), neglect of hygiene (<i>p</i> = 0.001, OR 13.22), loss of embarrassment (<i>p</i> = 0.003, OR 10.52), wandering (<i>p</i> = 0.004, OR 9.33), pacing (<i>p</i> = 0.014, OR 9), selfishness (<i>p</i> = 0.014, OR 9), increased smoking (<i>p</i> = 0.014, OR 9), increased alcohol consumption (<i>p</i> = 0.031, OR 7.36), social avoidance (<i>p</i> = 0.012, OR 6.93), mutism (<i>p</i> = 0.041, OR 5.67), and failure to recognize objects (<i>p</i> = 0.027, OR 4.33). The bvFTD patients were also significantly less suspicious (<i>p</i> = 0.001, OR 0.0295), less inclined to have a false belief that people were in their home (<i>p</i> = 0.014, OR 0.11) and had fewer visual illusions/hallucinations (<i>p</i> = 0.004, OR 0.107) than PDD patients. <b><i>Conclusion:</i></b> Behavioral symptoms are helpful to distinguish bvFTD from PDD, and thus also cortical dementia with frontal-lobe dysfunction from subcortical dementia.

Recognition of Famous and Unfamiliar Faces among Patients Suffering from Amnesia Mild Cognitive Impairment (AMCI) and Alzheimer’s Disease

Objective: Memory assessment for the early diagnosis of cortical dementia is a complicated process which depends on important factors such as facial recognition and naming. These factors could be considered to carry a predictive power to detect neurodegenerative disorders. The present study aimed to study and compare naming or recognizing famous faces with the recognition of newly learned faces among patients with Amnesia Mild Cognitive Impairment (AMCI) and Alzheimer’s disease. Method: To collect data, 60 AMCI patients, 62 patients suffering from Alzheimer’s disease, and 63 cognitively healthy individuals were assessed using Wechsler Memory Scale-III Faces test (WMS-III faces) and Famous Faces test. Results: The results of one-way ANOVA indicated that the patients suffering from AMCI and Alzheimer’s disease scored significantly worse than the control group on naming (p < 0.001), recognition (p < 0.001) section of the Famous Faces test, and immediate or delayed recognition on the WMS-III Faces test (p < 0.001). Also, the obtained results showed that the patients groups received lower scores on WMS-III Faces compared to the Famous Faces test. Conclusion: The results of this study suggested that the unfamiliar and Famous Faces tests allow the quantification of patients’ face recognition and name recall abilities which, in turn, makes it possible to make more accurate predictions about cases of dementia. These tests can be used for clinical and research purposes to screen those who may be prone to dementia and need further neuropsychological assessment.